Eli Lilly's Next-Gen Weight-Loss Drug Filing: A Game Changer for Investors
Eli Lilly's FDA filing for a new weight-loss drug could reshape the market landscape and challenge competitors like Novo Nordisk.
Celsius Holdings Soars on Rockstar Energy Founder’s Stake Acquisition
Russ Savage's acquisition of a stake in Celsius Holdings sparks speculation and market movement.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
NRx Pharmaceuticals Moves Closer to Launching Preservative-Free Ketamine
NRx Pharmaceuticals' ANDA for preservative-free ketamine passes FDA first-cycle review, signaling significant market pot…
Moderna's mRNA Flu Vaccine Approval: A Milestone with Market Implications
Moderna's recent FDA approval for its mRNA flu vaccine marks a significant step, yet market sentiment remains cautious.
Critical Minerals in Focus: Trump's Meeting with Mining CEOs and Its Market Implications
The Trump administration's focus on critical minerals highlights opportunities for investors in Lomiko Metals and Canadi…
US Jobs Report Shock: What the -23K Non-Farm Payrolls Mean for Markets
The unexpected -23,000 non-farm payrolls in July raises questions about market stability and economic outlook.
Harrow's Strategic Acquisition of TYRVAYA: A Game-Changer for Ophthalmic Treatments
Harrow's acquisition of TYRVAYA positions it as a key player in ophthalmic treatments, offering potential revenue growth…
Tarsus Pharmaceuticals Expands Eye Care Pipeline with Alkeus Acquisition
Tarsus Pharmaceuticals strengthens its eye care portfolio by acquiring Alkeus Pharmaceuticals, focusing on gildeuretinol…
Moderna's Groundbreaking mRNA Flu Vaccine Approval: A New Chapter in Vaccination
Moderna's mFLUSIVA, the first FDA-approved mRNA flu vaccine, is set to reshape the vaccination landscape and boost inves…
Harrow's Acquisition of TYRVAYA: A Game Changer for Dry Eye Treatment
Harrow Pharmaceuticals acquires TYRVAYA, the first FDA-approved nasal spray for dry eye disease, reshaping the market la…
Moderna's Historic mRNA Influenza Vaccine Approval: What It Means for Investors
Moderna's mFLUSIVA approval marks a pivotal moment for the company and its investors, showcasing its evolution beyond CO…